Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Второй международный консенсусный доклад о пробелах и возможностях клинической трансляции прецизионной медицины диабета
2023-10-01
SCID: 54.1/qr9qcvzd
Discuss with AI
clinical implementationclinical translationdiabetes heterogeneityprecision diabetes medicinesystematic evidence review
Figures from the paper
Abstract (AI)
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine.
Key Findings
1
Clinical readiness standards should incorporate cost-effectiveness, health equity, predictive accuracy, liability, and accessibility.
2
Major knowledge gaps remain, requiring new clinically relevant evidence to support translation of precision diabetes research into practice.
3
The consensus report systematically reviews evidence for precision medicine across prevention, diagnosis, treatment, and prognosis in monogenic, gestational, type 1, and type 2 diabetes.
4
The report defines key milestones needed for broad clinical implementation of precision diabetes medicine.
5
The review identifies opportunities for immediate or near-term clinical implementation of precision diabetes medicine despite incomplete coverage of the extensive literature.
Research Object
precision diabetes medicine across monogenic, gestational, type 1, and type 2 diabetes
Research Subject
clinical translation and implementation opportunities, knowledge gaps, and readiness requirements across prevention, diagnosis, treatment, and prognosis
Publication Details
Publication Date
2023-10-01
Journal
Publisher
ISSN
Cited by
233
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest